logo

For the Inventor, By the Inventor

South San Francisco, CA, United States of America

Alx Oncology Inc.


USPTO Granted Patents = 14



Forward Citations = 46

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal Hong Wan (13 out of 13 patents)

silverMedal Jaume Pons (13 out of 59 patents)

bronzeMedal Tracy Chia-Chien Kuo (11 out of 21 patents)

4.  Bang Janet Sim (11 out of 13 patents)

5.  Steven Elliot Kauder (7 out of 9 patents)

6.  Sophia Randolph (4 out of 4 patents)

7.  William Don Harriman (3 out of 34 patents)

8.  Shelley Izquierdo (3 out of 6 patents)

9.  Laura Deming (2 out of 2 patents)

10.  Corey Goodman (2 out of 2 patents)

11.  Marija Vrljic (1 out of 6 patents)

12.  Jaume Pons (1 out of 1 patent)


14 patents:

1. 12527838 - COMBINATION THERAPIES COMPRISING AN AGENT THAT BLOCKS THE INTERACTION BETWEEN CD47 AND SIRPa FOR TREATING GASTRIC OR GASTROESOPHAGEAL JUNCTION CANCER (2026-01-20),
2. 12404340 - Antibodies against signal-regulatory protein alpha and methods of use (2025-09-02),
3. 12343377 - Combination therapies comprising a hypomethylation agent for treating cancer (2025-07-01),
4. 12098214 - Combination therapies for treating cancer (2024-09-24),
5. 11939393 - Antibodies against signal-regulatory protein alpha and methods of use (2024-03-26),
6. 11939385 - Activatable antibodies and methods of use thereof (2024-03-26),
7. 11639376 - Constructs having a SIRP-α domain or variant thereof (2023-05-02),
8. 11613564 - Methods of treating cancer (2023-03-28),
9. 11401338 - Antibodies against signal-regulatory protein alpha and methods of use (2022-08-02),
10. 11292850 - Antibodies against signal-regulatory protein α and methods of use (2022-04-05),
11. 11242404 - Antibodies against signal-regulatory protein alpha and methods of use (2022-02-08),
12. 11208459 - Constructs having a SIRP-alpha domain or variant thereof (2021-12-28),
13. 10696730 - Constructs having a SIRP-alpha domain or variant thereof (2020-06-30),
14. 10259859 - Constructs having a SIRP-α domain or variant thereof (2019-04-16),
Company Overview
Alx Oncology Inc. is a biotechnology company based in South San Francisco, California, focused on developing innovative therapies for cancer treatment. The company specializes in harnessing the immune system to combat tumors, particularly through the development of monoclonal antibodies. Alx Oncology is dedicated to advancing its research in immuno-oncology, aiming to provide effective solutions for patients with various forms of cancer while addressing unmet medical needs in the oncology landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

Alx Oncology Inc. USPTO Patent Assignee Logo
14 Patents

#81 in South San Francisco, CA

#5,318 in California

#22,319 in US

#42,249 in the World

South San Francisco, CA (US)
South San Francisco, CA, United States of America

Alx Oncology Inc.

Forward Citations = 46

12 inventors:

goldMedal Hong Wan (13 out of 13 patents)

silverMedal Jaume Pons (13 out of 59 patents)

bronzeMedal Tracy Chia-Chien Kuo (11 out of 21 patents)

4.  Bang Janet Sim (11 out of 13 patents)

5.  Steven Elliot Kauder (7 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Alx Oncology Inc.. Retrieved from https://idiyas.com/company/alx-oncology

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…